A team of applied-AI engineers, focused on one thing: turning frontier agent research into systems that reach production. Built on the conviction that AI is an implementation problem, not a platform problem. Four production deployments and counting.
Most AI consultancies sell a platform. Buy our platform, the story goes, and your AI problems will solve themselves. They don't. The platform vendors have selection-bias success stories. Most builds fail in production. The MIT cascade-failure research documents why; the agent-scaling studies confirm it.
We don't sell a platform. We sell a methodology, a framework, and four catalyst deployments that back every recommendation we make. When we tell you to build a flow (not a peer mesh) for your lending LOS, we know it because we built one for IFHL.
When we tell you to put a confidence floor at 70% on a clinical CNN, we know it because the AIIMS Patna paediatrics team insisted on it. When we tell you to put a Raspberry Pi at the edge instead of moving meter data into the cloud, we know it because Omega Transmission's HT bill came down by 20%.
Amino acids are the fundamental units of natural life. Bots are the units of artificial systems. The name is the thesis.
Natural and artificial building blocks, fused into the systems we ship. The cascade in our mark is that idea made visible — small blocks, stacking until they reach production.
Kirti Ranjan, Founder & CEO — a key member of BRIDGEi2i's AI Labs (acquired by Accenture), where he led Advanced AI Capabilities at the Global AI Hub. Drop a note and we'll set up a slot this week.
A plain-English scorecard: is AI the right move, where's the return, and what to build first. If it won't pay off, we tell you before you build.